Conversely, in malignancies such as renal cell carcinoma and breast cancer, IL-18 manifests prototypical antitumour characteristics, including enhanced immune surveillance and tumour cell apoptosis induction56. The gene discussed is IL18; the disease is renal cell carcinoma.